Clinical trials
Death clinical trials
Below are recruiting death clinical trials, each written for real people, not researchers. We’re tracking 146 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06362525Recruiting
Episodes of Disconnected Consciousness in Emergency Patients
This study looks at brief episodes of being disconnected from your surroundings among very ill emergency patients. Researchers want to see how often this happens and what it means for recovery.
LiègeAges 18 years+ - NCT05288894Recruiting
Italian registry for people with repaired Tetralogy of Fallot
This trial is a registry that collects information about people who have had Tetralogy of Fallot (TOF) repaired. It may help doctors better understand long-term outcomes and improve future care.
Ancona, The MarchesAges 10 years+ - NCT03588286Recruiting
Check heart rhythm risk early after a heart attack
This trial tests whether a programmed heart rhythm test can better identify who needs an implanted defibrillator (ICD) soon after a heart attack. It may help prevent dangerous fast heart rhythms (tachyarrhythmias) by guiding who gets an ICD.
Boston, MassachusettsAges 18–85 - NCT07848997Recruiting
Urine test to help understand nearing end of life
This study collects urine samples from people with solid tumors to see if certain chemicals in the urine can help doctors understand how close someone is to the end of life. The goal is to improve care for patients in their final days.
Liverpool, MerseysideAges 18 years+ - NCT07849738Recruiting
Genetic testing after sudden cardiac death
This study looks at the DNA of young people who died suddenly without a clear cause, to find inherited heart conditions. If a genetic cause is found, close family members can be tested to learn their own risk and get preventive care.
São Paulo, São PauloAges 5–50 - NCT06394817Recruiting
Beijing Aging and Disability Risk Study
This study looks at how aging and disability risks affect people in the community. If you join, you will answer a survey to help researchers understand these issues better.
BeijingAges 60 years+ - NCT06472674Recruiting
Healthy Aging Study for Older Adults
This study is looking at healthy aging in older adults who live in the community. It involves completing a survey to help researchers understand how people age well.
BeijingAges 60 years+ - NCT07812831Enrolling by invitation
How health information changes over time
This study looks at how health information from people changes over time. The goal is to better understand normal patterns and spot when things change, which may help doctors improve care. You can join whether you have a medical condition or are generally healthy.
New York, New YorkAges 18 years+ - NCT06311149Recruiting
Study of LATITUDE heart device monitoring
This trial looks at how well the LATITUDE monitoring system works for people with heart devices. It checks if remote monitoring helps doctors track how your device is doing, so they can spot problems early.
FerraraAges Any age - NCT06383858Recruiting
Pre-eclampsia risk screening and prevention study
This study is for pregnant women to check their risk of pre-eclampsia (a serious condition causing high blood pressure) using simple tests like blood work or ultrasound. It aims to help you and your doctor manage your pregnancy better.
Guangzhou, GuangdongAges 18 years+ - NCT07751432Enrolling by invitation
Improving pregnancy care in a changing climate
This study works with clinics in Dar es Salaam, Tanzania to improve pregnancy care for women living in a city, especially as the climate changes. The goal is to help keep mothers and babies healthier.
Dar es Salaam, Temeke DistrictAges 18 years+ - NCT05679024RecruitingPhase 3
Apixaban to prevent stroke in atrial fibrillation and kidney failure
This trial tests apixaban (a blood thinner) to prevent stroke in people with atrial fibrillation or atrial flutter who have very poor kidney function or are on dialysis. If you qualify, you may help researchers find a safer way to lower stroke risk for this higher-risk group.
HelsinkiAges 18 years+ - NCT07728539Recruiting
Comparing a faster ablation method for atrial fibrillation
This study compares a newer, faster type of ablation (high-power short-duration) with the standard approach for treating atrial fibrillation. The goal is to see which method is safer and more effective at restoring a normal heart rhythm.
MoscowAges 18–70 - NCT07715617Recruiting
Creating a prediction score for lung transplant or death in Alpha-1 Antitrypsin Deficiency
This study is creating a simple scoring system to predict who with Alpha-1 Antitrypsin Deficiency-related emphysema might need a lung transplant or die from the disease. Your medical records from 2010–2025 will help build this tool, with no extra tests or visits required.
BronAges 18 years+ - NCT05936333Recruiting
Study why repeated pregnancy problems happen in some cases
This study looks at how the immune system may contribute to ongoing placenta inflammation in certain pregnancy histories. It may help researchers better understand causes behind pregnancy loss and related placental complications, using past placenta/tissue samples.
ClamartAges 18 years+ - NCT06267508Recruiting
HIV testing and treatment for newborns
This study looks at ways to test and treat newborns for HIV early to improve their long-term health. It is for mothers with HIV whose babies are less than 3 days old and who are willing to have their babies tested and followed at home.
BeiraAges 18 years+ - NCT05333367Recruiting
Study of how a light treatment causes immune cell death
This trial looks at how “extracorporeal photochemotherapy” (a light-based treatment done outside the body) works at the cellular level. It may help improve treatment and control for people dealing with immune reactions after transplant or certain blood/skin conditions.
BesançonAges 18–85 - NCT07618936Recruiting
PD-L1 PET/CT imaging scan for cancer patients
This trial tests a new type of imaging scan (PD-L1 PET/CT) that may help doctors better see and understand cancers. The scan uses a special tracer to highlight cancer cells in your body, which could help guide treatment decisions.
Hefei, AnhuiAges 18–80 - NCT05778981Recruiting
Study of blood-vessel health during non-heart surgery
This study looks at how blood-vessel function changes around the time of non-heart surgery, especially in people 45 and older. It may help doctors better understand risks and recovery related to blood-vessel stress during hospitalization.
Independencia, Santiago MetropolitanAges 45 years+ - NCT07527715Recruiting
Heart MRI Study for Dilated Heart Muscle Disease
This research uses cardiac MRI scans and patient data to better predict outcomes in people with dilated cardiomyopathy—a condition where the heart's main pumping chamber becomes enlarged and weakened. Participating could help doctors improve how they care for similar patients in the future.
Jinan, ShandongAges 18 years+ - NCT07531095RecruitingPhase 1
Combination drug trial for small cell lung cancer
This study tests three experimental drugs (tarlatamab, ZL-1310, and sometimes an immune-boosting drug) together to treat small cell lung cancer. The goal is to see if this combination can slow or shrink the cancer and help you live longer.
Goodyear, ArizonaAges 18–99 - NCT07504471RecruitingPhase 2
Bicarbonate plus chemo and immunotherapy for pancreatic cancer liver spread
This trial tests adding sodium bicarbonate to a chemotherapy plus immunotherapy regimen for pancreatic cancer that has spread to the liver. The goal is to see if this combination helps shrink tumors and improves outcomes.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06772454Recruiting
Testing a new drug combo for advanced lung cancer with COPD
This trial tests whether adding an immunotherapy drug (atezolizumab) to standard chemotherapy and inhaled steroids helps people with advanced lung cancer who also have COPD. The goal is to see if this combination improves outcomes.
Guangzhou, GuangdongAges 18 years+ - NCT02168088Recruiting
Study tissues to understand causes of sudden deaths
This trial collects and studies medical information and tissue from people who died suddenly with no clear cause, aiming to better identify hidden heart- and clot-related causes. It may help researchers improve how sudden deaths are investigated in the future.
La Jolla, CaliforniaAges Up to 45 years
Hear when a new Death trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for death?
- Yes. Clin2 currently lists 146 recruiting death studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a death trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a death trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.